Breast Cancer MammoSite® Radiation Therapy System (RTS)
Learn More About MammoSite RTS for Breast Cancer: Chat with Us | Email Us
Video: MammoSite® RTS for Breast Cancer
MammoSite® RTS for Breast CancerMammoSite® RTS for Breast Cancer
Listen to Dr. Bernard Eden describe this innovative form of brachytherapy which quickly and accurately delivers radiation to breast cancer tumors.
MammoSite® RTS for Breast Cancer
CTCA offers an innovative form of brachytherapy for breast cancer patients called MammoSite® Radiation Therapy System (RTS).
MammoSite RTS is a less invasive method of delivering breast brachytherapy than traditional high-dose rate (HDR) brachytherapy. Using a single catheter, your CTCA radiation oncologist inserts a balloon into the breast. Once inserted, the balloon is then expanded and radiation is delivered through tiny, radioactive seeds, irradiating the area surrounding the cavity.
With this type of breast cancer radiation therapy, our radiation oncologists deliver radiation directly to the area where a breast tumor has been surgically removed via lumpectomy. This is the site where tumors are most likely to recur. The radiation destroys any remaining breast cancer cells around the tumor cavity, while minimizing exposure to the surrounding healthy breast tissue.
Advantages of MammoSite® Radiation Therapy System
- While standard breast brachytherapy involves surgically implanting up to 24 catheters into the breast, MammoSite RTS calls for just a single balloon catheter to administer radiation treatment.
- By delivering internal doses of radiation directly to breast tumors, MammoSite RTS helps to avoid damage to surrounding healthy breast tissue and reduce some of the side effects associated with external beam radiation therapy.
- With its precise, site-specific approach, this form of breast cancer radiation therapy can be completed in as few as four or five days, compared to seven weeks for traditional external beam radiation therapy.
Next Topic: TomoTherapy® for Breast Cancer
